Genfit S.A. sell BiotechBee
Start price
27.06.23
/
70%
€3.56
Target price
31.01.26
€1.50
Performance (%)
-19.10%
End price
20.10.23
€2.88
Summary
This prediction ended on 20.10.23 with a price of €2.88. The prediction for Genfit S.A. closed with a convincing performance of -19.10%. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Genfit S.A. | 3.198% | 3.198% | 16.852% |
iShares Core DAX® | -3.033% | 0.651% | 12.268% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% |
According to BiotechBee what are the pros and cons of Genfit S.A. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Genfit S.A. diskutieren
Sell mit Kursziel 1,5
In the thread Trading Genfit S.A.
Sell beendet
Stopped prediction by BiotechBee for Genfit S.A.
Genfit S.A.
Start price
Target price
Perf. (%)
€3.32
10.12.23
10.12.23
€4.90
31.05.25
31.05.25
5.43%
17.02.24
17.02.24
Could be very worthwhile Investment >20% year